Akesiss Pharma Private Limited, a active private limited company, was established on 18 November 2008 in Kochi, Kerala, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232KL2008PTC023419. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹4.50 M and a paid-up capital of ₹4.50 M.
It upholds a compliant status. Employing 251 professional, Its leadership includes Sharatkumar Kumarakurup (Whole-Time Director), Padmadas Panjajanyam (Whole-Time Director), Ashok Kumar Kannampalam (Managing Director). Past directors included Sharatkumar Kumarakurup, Padmadas Panjajanyam, Thomsan George. It holds ₹3.99 Cr open charges and ₹1.83 Cr settled loans. Its latest AGM occurred on 28 September 2024, with the balance sheet filed on 31 March 2024. It is based at Rizwan Estate, Pathadipalam Edappally, Kochi, Kerala, 682024.
U24232KL2008PTC023419
023419
18 November 2008
₹4.50 M
₹4.50 M
Roc Ernakulam
Unlisted
Active
Explore comprehensive insights into Akesiss Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sharatkumar Kumarakurup | Whole-Time Director | 18 Nov 2008 | Current |
| Padmadas Panjajanyam | Whole-Time Director | 18 Nov 2008 | Current |
| Ashok Kumar Kannampalam | Managing Director | 18 Nov 2008 | Current |
| Thomsan George | Whole-Time Director | 18 Nov 2008 | Current |
| Narayan Biji | Director | 01 Jan 2013 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 18 Nov 2008 | Past |
| Pramod Abcsdd | Director | 18 Nov 2008 | Past |
| Pramod Abcsdd | Director | 18 Nov 2008 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Akesiss Pharma Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 3.96% increase. The company also saw a substantial improvement in profitability, with a 22.33% increase in profit. The company's net worth Soared by an impressive increase of 32.17%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Akesiss Pharma had a promoter holding of 62.07% and a public holding of 37.93%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹39,900,000.00
₹18,300,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Jun 2023 | Hdfc Bank Limited | ₹7.20 M | Open |
| 04 Nov 2022 | Others | ₹1.00 Cr | Open |
| 15 Jan 2022 | Hdfc Bank Limited | ₹0.70 M | Open |
| 15 Oct 2009 | State Bank Of India | ₹2.20 Cr | Open |
| 29 Mar 2017 | Others | ₹1.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Akesiss Pharma has a workforce of 251 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Akesiss Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Akesiss Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Akesiss Pharma Private Limited last Annual general meeting of members was held on 28 Sep 2024 as per latest MCA records. was documented.
Progress on Akesiss Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ernakulam. was documented.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 7.20 M with Charge ID 100745046 was registered on 27 Jun 2023. was documented.
A charge with Others amounted to Rs. 10.00 M with Charge ID 100644454 was registered on 04 Nov 2022. was recorded as a recent event.
Progress on A charge registered on 29 Mar 2017 via Charge ID 100092747 with Others was fully satisfied on 17 Sep 2022. was documented.
The activity A charge with State Bank Of India of Rs. 22.00 M registered on 15 Oct 2009 with Charge ID 10182516 was modified on 08 Jul 2022. was completed.
The CIN of Akesiss Pharma Private Limited is U24232KL2008PTC023419.
Akesiss Pharma Private Limited is headquartered at Rizwan Estate, Pathadipalam Edappally, Kochi, Kerala, 682024.
Akesiss Pharma Private Limited was incorporated on 18 November 2008.
The current directors of Akesiss Pharma Private Limited are
The primary industry of Akesiss Pharma Private Limited is Manufacturing.
Akesiss Pharma Private Limited is unlisted.
The authorized capital of Akesiss Pharma Private Limited is ₹4.50 M, and the paid-up capital is ₹4.50 M.
The compliance status of Akesiss Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX